Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Veterinary Intravenous Solutions Market: By Product Type, By End User, and Region Forecast 2019-2030
Veterinary Intravenous Solutions Market: By Product Type, By End User, and Region Forecast 2019-2030
Veterinary Intravenous Solutions Market size was valued at US$ 11.8 billion in 2023 and is poised to grow at a CAGR of 8% from 2024 to 2030 owing to increase in incidence of diseases affecting animals. Veterinary Intravenous Solutions are the nutritional products that are given to the animals when they are attacked by diseases such as pancreatitis. Increasing demand for pets and companion animals, high emphasis on animal wellness and health by veterinarians are expected to propel the growth of the market. Additionally, the emphasis on food safety, increased care towards animals, increasing need for nutrition-rich food are expected to enhance the sales of the market. However the awareness regarding the uses of veterinary intravenous solutions are limited and it is expected to limit the growth of the market.
Study Period
2025-2031Base Year
2024CAGR
8%Largest Market
North-AmericaFastest Growing Market
Asia Paciifc
Increase in the prevalence of diseases like foot and mouth disease, anthrax, pancreatitis and other diseases by which the feeding is not possible through mouth. According to a report by European Pet Food Industry Federation, over 75 million households in Europe own a pet and according to American Veterinary Medical Association more than half of U.S. households own pets and only 18.7 percent did not take their dog or dogs to a veterinarian. When animals get diseases like pancreatitis the feeding is not possible then these intravenous solutions are helpful to feed them. Increase in the demand for more nutritious food is anticipated to propel the global artificial joints market over the forecast years.
North America accounted for larger revenue share in global veterinary intravenous solutions market with significant CAGR owing to increasing number of pets in the houses, availability of advanced veterinary health care, rise in interest towards the disease prevention for the animals and limited natural source to feed the animals in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region are expected to grow at a significant growth rate over the forecast years owing to the increase in cattle rearing due to increase in demand for the milk and wool, government initiatives to rear cattle, government subsidies for animal rearing and the trend of owing pets.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 11.8 billion |
|
Market CAGR |
8% |
|
By Product Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The veterinary intravenous solutions market size was valued at US$ 11.8 billion in 2023 and is poised to grow at a CAGR of 8% from 2024 to 2030
Aspen Vet, Merck & Co., Inc. (MSD Veterinary Manual), Dechra Veterinary Products, Pfizer, Inc., Sypharma
North America is the fastest-growing region in the market
| 1. Executive Summary |
| 2. Global Veterinary Intravenous Solutions Market Introduction |
| 2.1.Global Veterinary Intravenous Solutions Market - Taxonomy |
| 2.2.Global Veterinary Intravenous Solutions Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3. Global Veterinary Intravenous Solutions Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Veterinary Intravenous Solutions Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Veterinary Intravenous Solutions Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Synthetic colloids |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Isotonic crystalloids |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Blood products |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Total parenteral nutrition |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Dextrose solutions |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Partial parenteral nutrition |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Veterinary Intravenous Solutions Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Veterinary Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Research Institutes |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.10. End Users |
| 6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.10.3. Market Opportunity Analysis |
| 7. Global Veterinary Intravenous Solutions Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Veterinary Intravenous Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Synthetic colloids |
| 8.1.2.Isotonic crystalloids |
| 8.1.3.Blood products |
| 8.1.4.Total parenteral nutrition |
| 8.1.5.Dextrose solutions |
| 8.1.6.Partial parenteral nutrition |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Veterinary Hospitals |
| 8.2.2.Research Institutes |
| 8.2.3.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Veterinary Intravenous Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Synthetic colloids |
| 9.1.2.Isotonic crystalloids |
| 9.1.3.Blood products |
| 9.1.4.Total parenteral nutrition |
| 9.1.5.Dextrose solutions |
| 9.1.6.Partial parenteral nutrition |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Veterinary Hospitals |
| 9.2.2.Research Institutes |
| 9.2.3.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Veterinary Intravenous Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Synthetic colloids |
| 10.1.2.Isotonic crystalloids |
| 10.1.3.Blood products |
| 10.1.4.Total parenteral nutrition |
| 10.1.5.Dextrose solutions |
| 10.1.6.Partial parenteral nutrition |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Veterinary Hospitals |
| 10.2.2.Research Institutes |
| 10.2.3.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Veterinary Intravenous Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Synthetic colloids |
| 11.1.2.Isotonic crystalloids |
| 11.1.3.Blood products |
| 11.1.4.Total parenteral nutrition |
| 11.1.5.Dextrose solutions |
| 11.1.6.Partial parenteral nutrition |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Veterinary Hospitals |
| 11.2.2.Research Institutes |
| 11.2.3.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Veterinary Intravenous Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Synthetic colloids |
| 12.1.2.Isotonic crystalloids |
| 12.1.3.Blood products |
| 12.1.4.Total parenteral nutrition |
| 12.1.5.Dextrose solutions |
| 12.1.6.Partial parenteral nutrition |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Veterinary Hospitals |
| 12.2.2.Research Institutes |
| 12.2.3.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Aspen Vet |
| 13.2.2.Merck & Co., Inc. (MSD Veterinary Manual) |
| 13.2.3.Dechra Veterinary Products |
| 13.2.4.Pfizer, Inc. |
| 13.2.5.Sypharma |
| 13.2.6.Animal Care Products. Inc., |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.